LY22-01b

Outcomes of autologous HCT and CD19 CAR-T in MYC+ large B-cell lymphoma patients.

Study #: LY22-01b

Study Status: Published

Autologous transplant or CAR-T as consolidation options in MYC rearranged large B-cell lymphoma patients in remission after salvage treatments.

Citation

Furqan F, Ahn KW, Kaur M, Patel J, Ansell S, Awan FT, Baird J, Bezerra E, Farooq U, Fung H, Khurana A, Lekakis L, Lutfi F, McCarty J, Mukherjee D, Nath R, Romancik J, Schuster SJ, Smith M, Winter A, Turtle C, Sauter C, Shadman M, Herrera A, Hamadani M.

American Journal of Hematology. 2025, Apr 15: (): . doi: 10.1002/ajh.27687. Epub 2025, Apr 15. PMCID:PMC12270545.

PubMed

PMID: 40231369

Abstract